|
||||||||||||||||
| Regd Office : 2nd Floor, 3rd Block, My Home Hub | ||||||||||||||||
| Madhapur, Hyderabad 500 081 | ||||||||||||||||
| UNAUDITED FINANCIAL RESULTS | ||||||||||||||||
| FOR THE QUARTER ENDED 31st MARCH, 2008 | ||||||||||||||||
| Rs. Lakhs | ||||||||||||||||
| S No | Particulars | Quarter ended 31st March 2008 | Quarter ended 31st March 2007 | 9 Months ended 31st March 2008 | 9 Months ended 31st March 2007 | Audited previous accounting year ended 30th June 2007 | ||||||||||
| 1 | Gross sales | 5,221.77 | 4,757.15 | 16,058.98 | 14,870.07 | 19,519.33 | ||||||||||
| Less : Excise Duty & Sales tax | 275.05 | 214.31 | 815.03 | 767.41 | 949.23 | |||||||||||
| 2 | Net sales/ Income from operations | 4,946.72 | 4,542.84 | 15,243.95 | 14,102.66 | 18,570.10 | ||||||||||
| 3 | Other Income | 22.69 | 60.92 | 72.06 | 130.28 | 246.31 | ||||||||||
| 4 | Total expenditure | |||||||||||||||
| a) (Increase)/decrease in stock in trade | (472.35) | 30.50 | (592.31) | (489.38) | 13.23 | |||||||||||
| b) Material consumption | 3,336.79 | 2,577.59 | 9,403.65 | 8,664.36 | 10,720.73 | |||||||||||
| c) Manufacturing expenses | 436.42 | 409.51 | 1,304.00 | 1,178.87 | 1,588.94 | |||||||||||
| d) Employee cost | 330.35 | 283.81 | 1,055.66 | 878.45 | 1,200.97 | |||||||||||
| e) Other expenditure | 483.36 | 435.60 | 1,669.70 | 1,460.70 | 1,923.29 | |||||||||||
| 5 | EBIDTA (2-4) | 832.16 | 805.83 | 2,403.25 | 2,409.66 | 3,122.94 | ||||||||||
| 6 | Interest and finance charges | 300.32 | 303.27 | 860.98 | 930.10 | 1,202.85 | ||||||||||
| 7 | Depreciation | 249.56 | 197.08 | 717.59 | 613.99 | 817.73 | ||||||||||
| 8 | Profit before taxation | 304.97 | 366.40 | 896.74 | 995.85 | 1,348.67 | ||||||||||
| 9 | Current tax expense | 29.54 | 11.51 | 87.69 | 24.17 | 43.93 | ||||||||||
| 10 | Deferred tax expense | 70.70 | 68.20 | 168.45 | 172.71 | 283.65 | ||||||||||
| 11 | Fringe Benefit Tax | 3.04 | 2.13 | 8.44 | 6.19 | 9.11 | ||||||||||
| 12 | Net Profit | 201.69 | 284.56 | 632.16 | 792.78 | 1,011.98 | ||||||||||
| 13 | Paid up share capital | 2,005.72 | 1,257.46 | 2,005.72 | 1,257.46 | 2,002.36 | ||||||||||
| (face value of Rs. 10/- each) | ||||||||||||||||
| 14 | Reserves excluding Revaluation reserve | 15,262.42 | ||||||||||||||
| 15 | Basic Earnings per share (Rs.)* | 1.01 | 2.26 | 3.15 | 6.30 | 7.63 | ||||||||||
| 16 | Diluted Earnings per share (Rs.)* | 0.93 | 1.86 | 2.92 | 5.17 | 6.81 | ||||||||||
| 17 | No. of equity shares | 20,057,154 | 12,574,609 | 20,057,154 | 12,574,609 | 20,023,634 | ||||||||||
| 18 | Aggregate of Public Share holding: | |||||||||||||||
| - Number of shares | 13,547,423 | 7,221,758 | 13,547,423 | 7,221,758 | 13,670,603 | |||||||||||
| - Percentage of share holding | 67.54% | 57.43% | 67.54% | 57.43% | 68.27% | |||||||||||
| * Not Annualised for quarter ending | ||||||||||||||||
| NOTES : | ||||||||||||||||
| 1) The above results were reviewed by the Audit Committee and approved by the Board at its meeting held on 30th April, | ||||||||||||||||
| 2008 and were subjected to limited review by Statutory Auditors. | ||||||||||||||||
| 2) The company has not received any complaints from investors during the quarter 1st January '08 to 31st March'08 | ||||||||||||||||
| and no complaints were pending from previous quarter. | ||||||||||||||||
| 3) The company operates only in the segment of Pharmaceuticals. | ||||||||||||||||
| 4) Diluted EPS includes 16,00,000 share warrants which are yet to be converted. | ||||||||||||||||
| 5) Figures are regrouped wherever necessary. | ||||||||||||||||
| for and on behalf of the Board | ||||||||||||||||
| Place : Hyderabad | Dr.C.Nageswara Rao | |||||||||||||||
| Date : 30.04.2008 | Chairman | |||||||||||||||